Medpage Today on MSN18h
Semaglutide Tied to Small Risk of Potentially Blinding Eye ConditionThe use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...
Tom Nolan reviews this week’s research Microplastics and nanoplastics (MNPs) are being found just about everywhere we look, and they have now been found in our brains. A report in Nature Medicine ...
A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. GLP-1 agonist drugs like Ozempic and Wegovy have surged in popularity during the last ...
Many patients with overweight or obesity discontinue glucagon-like peptide-1 receptor agonist therapy within one year.
Patients with type 1 diabetes comorbid with metabolic dysfunction-associated steatotic liver disease had a low prevalence of advanced liver fibrosis.
A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback